Takeda says retailers cannot bring US antitrust claims in Amitiza case
MLex Summary: Takeda Pharmaceuticals opposed retailer plaintiffs’ motion for judgment on the validity and enforceability of their assignments for antitrust claims in a US case over the drug Amitiza. “Retailer plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article